Two de novo UBR1 variants in trans as a cause of Johanson-Blizzard syndrome

被引:0
作者
Strych, Lukas [1 ,2 ]
Zavoral, Tomas [1 ,2 ]
Komrskova, Pavla [1 ,2 ]
Vanecek, Tomas [3 ,4 ]
Subrt, Ivan [1 ,2 ]
机构
[1] Charles Univ Prague, Fac Med Pilsen, Dept Med Genet, Plzen, Czech Republic
[2] Univ Hosp Plzen, Plzen, Czech Republic
[3] Univ Hosp Plzen, Sikls Dept Pathol, Plzen, Czech Republic
[4] Biopticka Lab S R O, Plzen, Czech Republic
来源
BIOMEDICAL PAPERS-OLOMOUC | 2025年
关键词
Johanson-Blizzard syndrome; UBR1; gene; novel variant; de novo; DE-NOVO MUTATIONS; END RULE PATHWAY; RECOGNITION COMPONENT; UBIQUITIN LIGASE; RING-H2; FINGER; RECOMMENDATION; VISUALIZATION; GENOMICS; PATIENT; GENES;
D O I
10.5507/bp.2025.005
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Aims/Background. Johanson-Blizzard syndrome (JBS) is a rare autosomal recessive disease caused by pathogenic variants in the UBR1 gene. JBS is usually suspected based on characteristic anomalies, but only genetic testing provides a definitive diagnosis. Since most variants are inherited from the parents, we aimed to identify the causal variants in a Czech proband with clinically suspected JBS and perform segregation analysis. Methods. A proband with clinically suspected JBS underwent clinical exome sequencing (CES). Sanger sequencing was used for the validation, characterization, and segregation of variants in the family. The variants were also characterized using quantitative real-time PCR (qPCR) and in silico analysis. Results. Using CES in the proband, we identified two novel causal variants in the UBR1 gene, c.3482A>C and c.3509+6T>C. Although the variants were found in trans, neither was detected in the parents. Sanger sequencing of the cDNA revealed that the novel variant c.3509+6T>C caused activation of the non-canonical GC donor splice site. The inclusion of 70 bp of the intronic sequence generated a frameshift and a premature termination codon leading to nonsense-mediated decay, as detected by qPCR. In silico protein structural analysis showed that the novel missense variant c.3482A>C in the zinc-stabilized domain RING-H2 altered a highly conserved zinc-coordinating histidine by proline. Conclusion. To the best of our knowledge, we report the first molecular confirmation of JBS in the Czech Republic and the first identification of two de novo causal variants in two alleles. Our findings also expand the spectrum of pathogenic variants in the UBR1 gene.
引用
收藏
页数:9
相关论文
共 55 条
  • [1] A method and server for predicting damaging missense mutations
    Adzhubei, Ivan A.
    Schmidt, Steffen
    Peshkin, Leonid
    Ramensky, Vasily E.
    Gerasimova, Anna
    Bork, Peer
    Kondrashov, Alexey S.
    Sunyaev, Shamil R.
    [J]. NATURE METHODS, 2010, 7 (04) : 248 - 249
  • [2] THE RECOGNITION COMPONENT OF THE N-END RULE PATHWAY
    BARTEL, B
    WUNNING, I
    VARSHAVSKY, A
    [J]. EMBO JOURNAL, 1990, 9 (10) : 3179 - 3189
  • [3] Personalized recurrence risk assessment following the birth of a child with a pathogenic de novo mutation
    Bernkopf, Marie
    Abdullah, Ummi B.
    Bush, Stephen J.
    Wood, Katherine A.
    Ghaffari, Sahar
    Giannoulatou, Eleni
    Koelling, Nils
    Maher, Geoffrey J.
    Thibaut, Loic M.
    Williams, Jonathan
    Blair, Edward M.
    Kelly, Fiona Blanco
    Bloss, Angela
    Burkitt-Wright, Emma
    Canham, Natalie
    Deng, Alexander T.
    Dixit, Abhijit
    Eason, Jacqueline
    Elmslie, Frances
    Gardham, Alice
    Hay, Eleanor
    Holder, Muriel
    Homfray, Tessa
    Hurst, Jane A.
    Johnson, Diana
    Jones, Wendy D.
    Kini, Usha
    Kivuva, Emma
    Kumar, Ajith
    Lees, Melissa M.
    Leitch, Harry G.
    Morton, Jenny E. V.
    Nemeth, Andrea H.
    Ramachandrappa, Shwetha
    Saunders, Katherine
    Shears, Deborah J.
    Side, Lucy
    Splitt, Miranda
    Stewart, Alison
    Stewart, Helen
    Suri, Mohnish
    Clouston, Penny
    Davies, Robert W.
    Wilkie, Andrew O. M.
    Goriely, Anne
    [J]. NATURE COMMUNICATIONS, 2023, 14 (01)
  • [4] Assessing the clinical utility of protein structural analysis in genomic variant classification: experiences from a diagnostic laboratory
    Caswell, Richard C.
    Gunning, Adam C.
    Owens, Martina M.
    Ellard, Sian
    Wright, Caroline F.
    [J]. GENOME MEDICINE, 2022, 14 (01)
  • [5] The conserved RING-H2 finger of ROC1 is required for ubiquitin ligation
    Chen, A
    Wu, K
    Fuchs, SY
    Tan, P
    Gomez, C
    Pan, ZQ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) : 15432 - 15439
  • [6] Accurate proteome-wide missense variant effect prediction with AlphaMissense
    Cheng, Jun
    Novati, Guido
    Pan, Joshua
    Bycroft, Clare
    Zemgulyte, Akvile
    Applebaum, Taylor
    Pritzel, Alexander
    Wong, Lai Hong
    Zielinski, Michal
    Sargeant, Tobias
    Schneider, Rosalia G.
    Senior, Andrew W.
    Jumper, John
    Hassabis, Demis
    Kohli, Pushmeet
    Avsec, Ziga
    [J]. SCIENCE, 2023, 381 (6664) : 1303 - +
  • [7] Carpal and tarsal synostoses and transverse reduction defects of the toes in two brothers heterozygous for a double de novo NOGGIN mutation
    Debeer, P
    Huysmans, C
    Van De Ven, WJM
    Fryns, JP
    Devriendt, K
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2005, 134A (03) : 318 - 320
  • [8] Pairs of dipeptides synergistically activate the binding of substrate by ubiquitin ligase through dissociation of its autoinhibitory domain
    Du, FY
    Navarro-Garcia, F
    Xia, ZX
    Tasaki, T
    Varshavsky, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (22) : 14110 - 14115
  • [9] LOVD v.2.0: The Next Generation in Gene Variant Databases
    Fokkema, Ivo F. A. C.
    Taschner, Peter E. M.
    Schaafsma, Gerard C. P.
    Celli, J.
    Laros, Jeroen F. J.
    den Dunnen, Johan T.
    [J]. HUMAN MUTATION, 2011, 32 (05) : 557 - 563
  • [10] How to Inactivate Human Ubiquitin E3 Ligases by Mutation
    Garcia-Barcena, Cristina
    Osinalde, Nerea
    Ramirez, Juanma
    Mayor, Ugo
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8